Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
ANKH - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 203 | 194 |
|
Invitae Skeletal Disorders Panel Invitae United States | 624 | 349 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital United States | 110 | 50 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Overgrowth and Macrocephaly Syndromes Panel PreventionGenetics United States | 150 | 88 |
|
Baylor Genetics United States | 842 | 637 |
|
Skeletal disease dysplasia panel with abnormal mineralization. 32-gene NGS panel. Genologica Medica Spain | 60 | 32 |
|
Osteoporosis and bone dysplasia panel. 25-gene NGS panel. Genologica Medica Spain | 56 | 25 |
|
Central skeletal dysplasias panel. NGS panel of 111 genes. Genologica Medica Spain | 258 | 111 |
|
Metaphyseal dysplasia panel. NGS panel of 11 genes. Genologica Medica Spain | 42 | 11 |
|
Chondrocalcinosis 2: Full gene sequencing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 1 |
|
Syndromic Hearing Loss NGS Panel Fulgent Genetics United States | 223 | 83 |
|
Comprehensive Hearing Loss NGS Panel Fulgent Genetics United States | 332 | 167 |
|
Craniometaphyseal Dysplasia (ANKH Single Gene Test) Fulgent Genetics United States | 2 | 1 |
|
Metaphyseal Dysplasia NGS Panel Fulgent Genetics United States | 37 | 10 |
|
Abnormal Mineralization NGS Panel Fulgent Genetics United States | 77 | 30 |
|
Abnormal Mineralization , Panel Massive Sequencing (NGS) 28 Genes Reference Laboratory Genetics Spain | 34 | 28 |
|
Skeletal dysplasia with abnormal mineralization Panel CeGaT GmbH Germany | 14 | 16 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.